1. The 4 Essential Baseline Lab Panels Explained
Before issuing an initial GLP-1 prescription, thorough clinical guidelines (including Obesity Medicine Association and Endocrine Society protocols) recommend ordering four baseline blood tests:
Comprehensive Metabolic Panel (CMP)
Evaluates renal markers (eGFR, serum creatinine, BUN) and hepatic transaminases (ALT, AST). Because GLP-1 therapies frequently induce transient nausea or decreased fluid intake, establishing baseline kidney filtration is crucial to prevent acute kidney injury (AKI) from secondary dehydration.
Hemoglobin A1c (HbA1c)
Measures your 90-day average blood sugar. If your A1c is ≥ 6.5%, you meet diagnostic criteria for Type 2 Diabetes, which dramatically expands insurance coverage options (e.g., Ozempic or Mounjaro on commercial formularies) compared to standalone obesity indications.
Fasting Lipid Profile
Measures LDL, HDL, total cholesterol, and triglycerides. Significantly elevated triglycerides (> 500 mg/dL) represent an independent risk factor for acute pancreatitis; establishing baseline lipid counts helps your doctor safeguard pancreatic health.
Thyroid Stimulating Hormone (TSH)
Screens for unmanaged primary hypothyroidism, which can cause secondary weight gain and lethargy. Correcting thyroid hormone deficiency is an essential prerequisite before starting metabolic therapy.